Lv53
1470 积分 2021-08-16 加入
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
16分钟前
求助中
Barriers to CAR T-cell therapy in rheumatology
1天前
已完结
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial
3天前
已完结
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial
3天前
已完结
Systemic lupus erythematosus
24天前
已完结
IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases
28天前
已完结
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial
1个月前
已完结
Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial
1个月前
已完结
Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition
1个月前
已完结
Effectiveness, safety, and cost of combination advanced therapies in inflammatory bowel disease
1个月前
已完结
皖公网安备34019202002308
